Correlation Between Monte Rosa and Effector Therapeutics
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Effector Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Effector Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and Effector Therapeutics, you can compare the effects of market volatilities on Monte Rosa and Effector Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Effector Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Effector Therapeutics.
Diversification Opportunities for Monte Rosa and Effector Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Monte and Effector is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Effector Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Effector Therapeutics and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Effector Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Effector Therapeutics has no effect on the direction of Monte Rosa i.e., Monte Rosa and Effector Therapeutics go up and down completely randomly.
Pair Corralation between Monte Rosa and Effector Therapeutics
Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to generate 0.76 times more return on investment than Effector Therapeutics. However, Monte Rosa Therapeutics is 1.31 times less risky than Effector Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Effector Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 659.00 in Monte Rosa Therapeutics on November 2, 2024 and sell it today you would lose (2.00) from holding Monte Rosa Therapeutics or give up 0.3% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 70.85% |
| Values | Daily Returns |
Monte Rosa Therapeutics vs. Effector Therapeutics
Performance |
| Timeline |
| Monte Rosa Therapeutics |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Monte Rosa and Effector Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monte Rosa and Effector Therapeutics
The main advantage of trading using opposite Monte Rosa and Effector Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Effector Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Effector Therapeutics will offset losses from the drop in Effector Therapeutics' long position.| Monte Rosa vs. Nkarta Inc | Monte Rosa vs. Lyell Immunopharma | Monte Rosa vs. Generation Bio Co | Monte Rosa vs. Sana Biotechnology |
| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |